TY - JOUR
T1 - High Energy Particle Radiation-associated Oncogenic Transformation in Normal Mice
T2 - Insight into the Connection between Activation of Oncotargets and Oncogene Addiction
AU - Aravindan, Natarajan
AU - Aravindan, Sheeja
AU - Manickam, Krishnan
AU - Natarajan, Mohan
N1 - Funding Information:
This study was supported by the NASA Ground-Based Studies in Space Radiobiology, Grant NNX12-AC32G. The authors acknowledge the University of Oklahoma SCC-Cancer Tissue Pathology Core for all TMA and IHC services and the SCC-Cancer Functional Genomics Core for high-content confocal imaging services. We would also like to thank Drs. Peter Guida and Adam Rusek and their teams at the NASA Space Radiation Laboratory (NSRL), Brookhaven National Laboratory, Upton, NY. The authors acknowledge the OUHSC Office of the Vice President for Research, Staff Editor (Ms. Kathy Kyler) for help in critically reviewing this manuscript.
Publisher Copyright:
© The Author(s) 2016.
PY - 2016/11/23
Y1 - 2016/11/23
N2 - Concerns on high-energy particle radiation-induced tumorigenic transformation of normal tissue in astronauts, and in cancer patients undergoing radiotherapy, emphasizes the significance of elucidating the mechanisms involved in radiogenic transformation processes. Mostly used genetically modified or tumor-prone models are less reliable in determining human health risk in space or protracted post-treatment normal tissue toxicity. Here, in wild type C57BL/6 mice, we related the deregulation of distinctive set of tissue-specific oncotargets in major organs upon 56Fe (600 MeV/amu; 0.5 Gy/min; 0.8 Gy) particle radiation and compared the response with low LET γ-radiation (137Cs; 0.5 Gy/min; 2 Gy). One of the novel findings is the 'tissue-independent' activation of TAL2 upon high-energy radiation, and thus qualifies TAL2 as a potential biomarker for particle and other qualities of radiation. Heightened expression of TAL2 gene transcript, which sustained over four weeks post-irradiation foster the concept of oncogene addiction signaling in radiogenic transformation. The positive/negative expression of other selected oncotargets that expresses tissue-dependent manner indicated their role as a secondary driving force that addresses the diversity of tissue-dependent characteristics of tumorigenesis. This study, while reporting novel findings on radiogenic transformation of normal tissue when exposed to particle radiation, it also provides a platform for further investigation into different radiation quality, LET and dose/dose rate effect in healthy organs.
AB - Concerns on high-energy particle radiation-induced tumorigenic transformation of normal tissue in astronauts, and in cancer patients undergoing radiotherapy, emphasizes the significance of elucidating the mechanisms involved in radiogenic transformation processes. Mostly used genetically modified or tumor-prone models are less reliable in determining human health risk in space or protracted post-treatment normal tissue toxicity. Here, in wild type C57BL/6 mice, we related the deregulation of distinctive set of tissue-specific oncotargets in major organs upon 56Fe (600 MeV/amu; 0.5 Gy/min; 0.8 Gy) particle radiation and compared the response with low LET γ-radiation (137Cs; 0.5 Gy/min; 2 Gy). One of the novel findings is the 'tissue-independent' activation of TAL2 upon high-energy radiation, and thus qualifies TAL2 as a potential biomarker for particle and other qualities of radiation. Heightened expression of TAL2 gene transcript, which sustained over four weeks post-irradiation foster the concept of oncogene addiction signaling in radiogenic transformation. The positive/negative expression of other selected oncotargets that expresses tissue-dependent manner indicated their role as a secondary driving force that addresses the diversity of tissue-dependent characteristics of tumorigenesis. This study, while reporting novel findings on radiogenic transformation of normal tissue when exposed to particle radiation, it also provides a platform for further investigation into different radiation quality, LET and dose/dose rate effect in healthy organs.
UR - http://www.scopus.com/inward/record.url?scp=84996590129&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84996590129&partnerID=8YFLogxK
U2 - 10.1038/srep37623
DO - 10.1038/srep37623
M3 - Article
C2 - 27876887
AN - SCOPUS:84996590129
SN - 2045-2322
VL - 6
JO - Scientific reports
JF - Scientific reports
M1 - 37623
ER -